| Business Summary | | Genaissance
Pharmaceuticals
Inc.
develops
technology
for
applying
population
genomics
to
improve
the
development,
marketing
and
prescribing
of
drugs.
The
Company
discovers
genomic
markers
that
can
be
used
to
predict
which
patients
will
respond
effectively
to
a
drug.
The
Company
combines
sophisticated
informatics
and
proprietary
procedures
with
DNA
sequencing
and
genomic
variation
measurement
capabilities
to
allow
pharmaceutical
companies
to
integrate
population
genomics
into
the
development,
marketing
and
prescribing
of
new
and
existing
medicines.
The
Company
has
invested
considerable
resources
in
constructing
a
production
process
to
discover
genomic
variation
with
the
goal
of
discovering
the
range
of
genomic
variation
among
all
of
the
pharmaceutically
relevant
genes.
The
Company
calls
this
complete
solution
its
HAP
Technology. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | GNSC
develops
technology
for
applying
population
genomics
and
informatics
to
improve
the
development,
marketing
and
prescribing
of
drugs.
For
the
six
months
ended
6/30/01,
revenues
totaled
$2.1
million,
up
from
$120
thousand.
Net
loss
applicable
to
Common
decreased
65%
to
$24.4
million.
Revenues
reflect
higher
license
revenues
due
to
the
commercialization
of
the
Company's
HAP
program.
Lower
loss
also
reflects
the
absence
of
a
$50.2
million
beneficial
conversion
and
dividend. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Jurgen Drews, M.D., 67 Chairman | -- | -- | Gualberto Ruano, M.D, Ph.D., 41 CEO,
Director | $930K | -- | Kevin Rakin, 40 Pres,
CFO, Director | 581K | -- | Kenneth Kashkin, M.D., 50 Exec.
VP and CMO | 131K | -- | Gerald Vovis, Ph.D., 58 Sr.
VP, CTO | 223K | $95K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|